Bone Marrow TransplantationBone MarrowBone Marrow CellsTissue DonorsTransplant Donor SiteTransplantation, HomologousGraft vs Host DiseaseBone and BonesTransplantation ChimeraLiving DonorsWhole-Body IrradiationKidney TransplantationTransplantation, AutologousGraft SurvivalAnemia, AplasticLeukemiaHistocompatibility TestingTransplantation ConditioningHematopoietic Stem CellsHistocompatibilityHematopoietic Stem Cell TransplantationBone Marrow DiseasesBone Marrow PurgingBone RemodelingBone Marrow ExaminationRadiation ChimeraGraft RejectionMice, Inbred C57BLBone Marrow NeoplasmsImmunosuppressive AgentsTransplantation, IsogeneicHematopoiesisImmunosuppressionBusulfanLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRecurrenceTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaTreatment OutcomeBone DensityLeukemia, Myeloid, AcuteHLA AntigensCyclophosphamideLymphocyte DepletionLeukocyte TransfusionHematologic NeoplasmsTransplantation ToleranceT-LymphocytesGraft Enhancement, ImmunologicAcute DiseaseCytomegalovirus InfectionsBone ResorptionLiver TransplantationColony-Forming Units AssayCombined Modality TherapyTransplantation ImmunologySurvival AnalysisActuarial AnalysisSkin TransplantationHeart TransplantationLeukemia, MyeloidChimerismCell DifferentiationGraft vs Host ReactionRemission InductionChimeraCyclosporineHepatic Veno-Occlusive DiseaseMice, Inbred BALB CRetrospective StudiesMyelodysplastic SyndromesBone NeoplasmsHematologic DiseasesLymphoma, Non-HodgkinFlow CytometryLymphocyte TransfusionCells, CulturedOpportunistic InfectionsNuclear FamilyImmunocompromised HostSpleenBone DevelopmentDisease-Free SurvivalStem Cell TransplantationSevere Combined ImmunodeficiencyBone DiseasesLymphocyte Culture Test, MixedFatal OutcomeLeukocyte CountAntigens, CD34Multiple MyelomaPancytopeniaGranulocytesGranulocyte Colony-Stimulating FactorFollow-Up StudiesSurvival RateAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred C3HMice, KnockoutStromal Cells